SARS-CoV-2 incidence, transmission and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-2021
By August 2021, South Africa experienced three SARS-CoV-2 waves; the second and third associated with emergence of Beta and Delta variants respectively. We conducted a prospective cohort study during July 2020-August 2021 in one rural and one urban community. Mid-turbinate nasal swabs were collected...
Saved in:
Published in | medRxiv : the preprint server for health sciences |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
04.12.2021
|
Online Access | Get more information |
Cover
Loading…
Abstract | By August 2021, South Africa experienced three SARS-CoV-2 waves; the second and third associated with emergence of Beta and Delta variants respectively.
We conducted a prospective cohort study during July 2020-August 2021 in one rural and one urban community. Mid-turbinate nasal swabs were collected twice-weekly from household members irrespective of symptoms and tested for SARS-CoV-2 using real-time reverse transcription polymerase chain reaction (rRT-PCR). Serum was collected every two months and tested for anti-SARS-CoV-2 antibodies.
Among 115,759 nasal specimens from 1,200 members (follow-up rate 93%), 1976 (2%) were SARS-CoV-2-positive. By rRT-PCR and serology combined, 62% (749/1200) of individuals experienced ≥1 SARS-CoV-2 infection episode, and 12% (87/749) experienced reinfection. Of 662 PCR-confirmed episodes with available data, 15% (n=97) were associated with ≥1 symptom. Among 222 households, 200 (90%) had ≥1 SARS-CoV-2-positive individual. Household cumulative infection risk (HCIR) was 25% (213/856). On multivariable analysis, accounting for age and sex, index case lower cycle threshold value (OR 3.9, 95%CI 1.7-8.8), urban community (OR 2.0,95%CI 1.1-3.9), Beta (OR 4.2, 95%CI 1.7-10.1) and Delta (OR 14.6, 95%CI 5.7-37.5) variant infection were associated with increased HCIR. HCIR was similar for symptomatic (21/110, 19%) and asymptomatic (195/775, 25%) index cases (p=0.165). Attack rates were highest in individuals aged 13-18 years and individuals in this age group were more likely to experience repeat infections and to acquire SARS-CoV-2 infection. People living with HIV who were not virally supressed were more likely to develop symptomatic illness, and shed SARS-CoV-2 for longer compared to HIV-uninfected individuals.
In this study, 85% of SARS-CoV-2 infections were asymptomatic and index case symptom status did not affect HCIR, suggesting a limited role for control measures targeting symptomatic individuals. Increased household transmission of Beta and Delta variants, likely contributed to successive waves, with >60% of individuals infected by the end of follow-up.
Previous studies have generated wide-ranging estimates of the proportion of SARS-CoV-2 infections which are asymptomatic. A recent systematic review found that 20% (95% CI 3%-67%) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections remained asymptomatic throughout infection and that transmission from asymptomatic individuals was reduced. A systematic review and meta-analysis of 87 household transmission studies of SARS-CoV-2 found an estimated secondary attack rate of 19% (95% CI 16-22). The review also found that household secondary attack rates were increased from symptomatic index cases and that adults were more likely to acquire infection. As of December 2021, South Africa experienced three waves of SARS-CoV-2 infections; the second and third waves were associated with circulation of Beta and Delta variants respectively. SARS-CoV-2 vaccines became available in February 2021, but uptake was low in study sites reaching 5% fully vaccinated at the end of follow up. Studies to quantify the burden of asymptomatic infections, symptomatic fraction, reinfection frequency, duration of shedding and household transmission of SARS-CoV-2 from asymptomatically infected individuals have mostly been conducted as part of outbreak investigations or in specific settings. Comprehensive systematic community studies of SARS-CoV-2 burden and transmission including for the Beta and Delta variants are lacking, especially in low vaccination settings.
We conducted a unique detailed COVID-19 household cohort study over a 13 month period in South Africa, with real time reverse transcriptase polymerase chain reaction (rRT-PCR) testing twice a week irrespective of symptoms and bimonthly serology. By the end of the study in August 2021, 749 (62%) of 1200 individuals from 222 randomly sampled households in a rural and an urban community in South Africa had at least one confirmed SARS-CoV-2 infection, detected on rRT-PCR and/or serology, and 12% (87/749) experienced reinfection. Symptom data were analysed for 662 rRT-PCR-confirmed infection episodes that occurred >14 days after the start of follow-up (of a total of 718 rRT-PCR-confirmed episodes), of these, 15% (n=97) were associated with one or more symptoms. Among symptomatic indvidiausl, 9% (n=9) were hospitalised and 2% (n=2) died. Ninety percent (200/222) of included households, had one or more individual infected with SARS-CoV-2 on rRT-PCR and/or serology within the household. SARS-CoV-2 infected index cases transmitted the infection to 25% (213/856) of susceptible household contacts. Index case ribonucleic acid (RNA) viral load proxied by rRT-PCR cycle threshold value was strongly predictive of household transmission. Presence of symptoms in the index case was not associated with household transmission. Household transmission was four times greater from index cases infected with Beta variant and fifteen times greater from index cases infected with Delta variant compared to wild-type infection. Attack rates were highest in individuals aged 13-18 years and individuals in this age group were more likely to experience repeat infections and to acquire SARS-CoV-2 infection within households. People living with HIV (PLHIV) who were not virally supressed were more likely to develop symptomatic illness when infected with SARS-CoV-2, and shed SARS-CoV-2 for longer when compared to HIV-uninfected individuals.
We found a high rate of SARS-CoV-2 infection in households in a rural community and an urban community in South Africa, with the majority of infections being asymptomatic in individuals of all ages. Asymptomatic individuals transmitted SARS-CoV-2 at similar levels to symptomatic individuals suggesting that interventions targeting symptomatic individuals such as symptom-based testing and contact tracing of individuals tested because they report symptoms may have a limited impact as control measures. Increased household transmission of Beta and Delta variants, likely contributed to recurrent waves of COVID-19, with >60% of individuals infected by the end of follow-up. Higher attack rates, reinfection and acquisition in adolescents and prolonged SARS-CoV-2 shedding in PLHIV who were not virally suppressed suggests that prioritised vaccination of individuals in these groups could impact community transmission. |
---|---|
AbstractList | By August 2021, South Africa experienced three SARS-CoV-2 waves; the second and third associated with emergence of Beta and Delta variants respectively.
We conducted a prospective cohort study during July 2020-August 2021 in one rural and one urban community. Mid-turbinate nasal swabs were collected twice-weekly from household members irrespective of symptoms and tested for SARS-CoV-2 using real-time reverse transcription polymerase chain reaction (rRT-PCR). Serum was collected every two months and tested for anti-SARS-CoV-2 antibodies.
Among 115,759 nasal specimens from 1,200 members (follow-up rate 93%), 1976 (2%) were SARS-CoV-2-positive. By rRT-PCR and serology combined, 62% (749/1200) of individuals experienced ≥1 SARS-CoV-2 infection episode, and 12% (87/749) experienced reinfection. Of 662 PCR-confirmed episodes with available data, 15% (n=97) were associated with ≥1 symptom. Among 222 households, 200 (90%) had ≥1 SARS-CoV-2-positive individual. Household cumulative infection risk (HCIR) was 25% (213/856). On multivariable analysis, accounting for age and sex, index case lower cycle threshold value (OR 3.9, 95%CI 1.7-8.8), urban community (OR 2.0,95%CI 1.1-3.9), Beta (OR 4.2, 95%CI 1.7-10.1) and Delta (OR 14.6, 95%CI 5.7-37.5) variant infection were associated with increased HCIR. HCIR was similar for symptomatic (21/110, 19%) and asymptomatic (195/775, 25%) index cases (p=0.165). Attack rates were highest in individuals aged 13-18 years and individuals in this age group were more likely to experience repeat infections and to acquire SARS-CoV-2 infection. People living with HIV who were not virally supressed were more likely to develop symptomatic illness, and shed SARS-CoV-2 for longer compared to HIV-uninfected individuals.
In this study, 85% of SARS-CoV-2 infections were asymptomatic and index case symptom status did not affect HCIR, suggesting a limited role for control measures targeting symptomatic individuals. Increased household transmission of Beta and Delta variants, likely contributed to successive waves, with >60% of individuals infected by the end of follow-up.
Previous studies have generated wide-ranging estimates of the proportion of SARS-CoV-2 infections which are asymptomatic. A recent systematic review found that 20% (95% CI 3%-67%) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections remained asymptomatic throughout infection and that transmission from asymptomatic individuals was reduced. A systematic review and meta-analysis of 87 household transmission studies of SARS-CoV-2 found an estimated secondary attack rate of 19% (95% CI 16-22). The review also found that household secondary attack rates were increased from symptomatic index cases and that adults were more likely to acquire infection. As of December 2021, South Africa experienced three waves of SARS-CoV-2 infections; the second and third waves were associated with circulation of Beta and Delta variants respectively. SARS-CoV-2 vaccines became available in February 2021, but uptake was low in study sites reaching 5% fully vaccinated at the end of follow up. Studies to quantify the burden of asymptomatic infections, symptomatic fraction, reinfection frequency, duration of shedding and household transmission of SARS-CoV-2 from asymptomatically infected individuals have mostly been conducted as part of outbreak investigations or in specific settings. Comprehensive systematic community studies of SARS-CoV-2 burden and transmission including for the Beta and Delta variants are lacking, especially in low vaccination settings.
We conducted a unique detailed COVID-19 household cohort study over a 13 month period in South Africa, with real time reverse transcriptase polymerase chain reaction (rRT-PCR) testing twice a week irrespective of symptoms and bimonthly serology. By the end of the study in August 2021, 749 (62%) of 1200 individuals from 222 randomly sampled households in a rural and an urban community in South Africa had at least one confirmed SARS-CoV-2 infection, detected on rRT-PCR and/or serology, and 12% (87/749) experienced reinfection. Symptom data were analysed for 662 rRT-PCR-confirmed infection episodes that occurred >14 days after the start of follow-up (of a total of 718 rRT-PCR-confirmed episodes), of these, 15% (n=97) were associated with one or more symptoms. Among symptomatic indvidiausl, 9% (n=9) were hospitalised and 2% (n=2) died. Ninety percent (200/222) of included households, had one or more individual infected with SARS-CoV-2 on rRT-PCR and/or serology within the household. SARS-CoV-2 infected index cases transmitted the infection to 25% (213/856) of susceptible household contacts. Index case ribonucleic acid (RNA) viral load proxied by rRT-PCR cycle threshold value was strongly predictive of household transmission. Presence of symptoms in the index case was not associated with household transmission. Household transmission was four times greater from index cases infected with Beta variant and fifteen times greater from index cases infected with Delta variant compared to wild-type infection. Attack rates were highest in individuals aged 13-18 years and individuals in this age group were more likely to experience repeat infections and to acquire SARS-CoV-2 infection within households. People living with HIV (PLHIV) who were not virally supressed were more likely to develop symptomatic illness when infected with SARS-CoV-2, and shed SARS-CoV-2 for longer when compared to HIV-uninfected individuals.
We found a high rate of SARS-CoV-2 infection in households in a rural community and an urban community in South Africa, with the majority of infections being asymptomatic in individuals of all ages. Asymptomatic individuals transmitted SARS-CoV-2 at similar levels to symptomatic individuals suggesting that interventions targeting symptomatic individuals such as symptom-based testing and contact tracing of individuals tested because they report symptoms may have a limited impact as control measures. Increased household transmission of Beta and Delta variants, likely contributed to recurrent waves of COVID-19, with >60% of individuals infected by the end of follow-up. Higher attack rates, reinfection and acquisition in adolescents and prolonged SARS-CoV-2 shedding in PLHIV who were not virally suppressed suggests that prioritised vaccination of individuals in these groups could impact community transmission. |
Author | Kleynhans, Jackie Viboud, Cécile Wolter, Nicole Tempia, Stefano Sun, Kaiyun Wafawanaka, Floidy Tollman, Stephen Cohen, Cheryl Dawood, Fatimah S von Gottberg, Anne Mkhencele, Thulisa McMorrow, Meredith L du Toit, Jacques Buys, Amelia Martinson, Neil A Kahn, Kathleen Moyes, Jocelyn du Plessis, Mignon Lebina, Limakatso Xavier Gómez-Olivé, Francesc Bhiman, Jinal N Carrim, Maimuna |
Author_xml | – sequence: 1 givenname: Cheryl surname: Cohen fullname: Cohen, Cheryl organization: School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa – sequence: 2 givenname: Jackie surname: Kleynhans fullname: Kleynhans, Jackie organization: School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa – sequence: 3 givenname: Anne surname: von Gottberg fullname: von Gottberg, Anne organization: School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa – sequence: 4 givenname: Meredith L surname: McMorrow fullname: McMorrow, Meredith L organization: Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America – sequence: 5 givenname: Nicole surname: Wolter fullname: Wolter, Nicole organization: School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa – sequence: 6 givenname: Jinal N surname: Bhiman fullname: Bhiman, Jinal N organization: School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa – sequence: 7 givenname: Jocelyn surname: Moyes fullname: Moyes, Jocelyn organization: School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa – sequence: 8 givenname: Mignon surname: du Plessis fullname: du Plessis, Mignon organization: School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa – sequence: 9 givenname: Maimuna surname: Carrim fullname: Carrim, Maimuna organization: School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa – sequence: 10 givenname: Amelia surname: Buys fullname: Buys, Amelia organization: Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa – sequence: 11 givenname: Neil A surname: Martinson fullname: Martinson, Neil A organization: Johns Hopkins University Center for TB Research, Baltimore, Maryland, United States of America – sequence: 12 givenname: Kathleen surname: Kahn fullname: Kahn, Kathleen organization: MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), Faculty of Health Sciences, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa – sequence: 13 givenname: Stephen surname: Tollman fullname: Tollman, Stephen organization: MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), Faculty of Health Sciences, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa – sequence: 14 givenname: Limakatso surname: Lebina fullname: Lebina, Limakatso organization: Africa Health Research Institute, KwaZulu-Natal, South Africa – sequence: 15 givenname: Floidy surname: Wafawanaka fullname: Wafawanaka, Floidy organization: MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), Faculty of Health Sciences, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa – sequence: 16 givenname: Jacques surname: du Toit fullname: du Toit, Jacques organization: MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), Faculty of Health Sciences, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa – sequence: 17 givenname: Francesc surname: Xavier Gómez-Olivé fullname: Xavier Gómez-Olivé, Francesc organization: MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), Faculty of Health Sciences, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa – sequence: 18 givenname: Fatimah S surname: Dawood fullname: Dawood, Fatimah S organization: Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America – sequence: 19 givenname: Thulisa surname: Mkhencele fullname: Mkhencele, Thulisa organization: Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa – sequence: 20 givenname: Kaiyun surname: Sun fullname: Sun, Kaiyun organization: Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, MD, USA – sequence: 21 givenname: Cécile surname: Viboud fullname: Viboud, Cécile organization: Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, MD, USA – sequence: 22 givenname: Stefano surname: Tempia fullname: Tempia, Stefano organization: Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34909794$$D View this record in MEDLINE/PubMed |
BookMark | eNo1UEtOwzAU9ALEp3ACJOQDNMF27KRmV0VAK1UCNYVt5djPxFLrVLaz6DG4MSmfzRvNR6PRu0ZnvveA0B0lOaWEPjDCaE6qnJGcUVaSmRAX6LLgkshK8iv01czXTVb3HxnDzmtnwGuY4hSUj3sXo-s9Vt7gAM5b0OnE3SjhMAS1-7GUx0NoxxshJec_H8dwHHYp4t7i1AF-WyzXzSarse67PiQc02COU9z0Q-rw3Aan1RSPQ0l2WnuDzq3aRbj9wwl6f37a1Its9fqyrOerTDNSigwUNUXLWgrUUmgVyLLgqlJcFUwKrgQHrbhkoiRSGctLPdMWKkGNNC1YwSbo_rf3MLR7MNtDcHsVjtv_37BvOgxhKA |
CitedBy_id | crossref_primary_10_1093_cid_ciab952 crossref_primary_10_1126_science_abn4947 crossref_primary_10_3390_v14061222 crossref_primary_10_1111_irv_12997 crossref_primary_10_3390_v15102100 crossref_primary_10_1038_s41467_023_36449_5 crossref_primary_10_1099_mgen_0_000993 crossref_primary_10_1001_jamanetworkopen_2022_9317 |
ContentType | Journal Article |
CorporateAuthor | PHIRST group |
CorporateAuthor_xml | – name: PHIRST group |
DBID | NPM |
DOI | 10.1101/2021.07.20.21260855 |
DatabaseName | PubMed |
DatabaseTitle | PubMed |
DatabaseTitleList | PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
ExternalDocumentID | 34909794 |
Genre | Preprint |
GrantInformation_xml | – fundername: ACL HHS grantid: U01IP001048 – fundername: Wellcome Trust – fundername: NCIRD CDC HHS grantid: U01 IP001048 |
GroupedDBID | NPM |
ID | FETCH-LOGICAL-c2065-ea1d3b2b1e1f1ebae9634a7a4a32954a54eca4925609adf46c8cfe751d9dbef52 |
IngestDate | Sat Nov 02 12:30:16 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c2065-ea1d3b2b1e1f1ebae9634a7a4a32954a54eca4925609adf46c8cfe751d9dbef52 |
OpenAccessLink | http://www.thelancet.com/article/S147330992200069X/pdf |
PMID | 34909794 |
ParticipantIDs | pubmed_primary_34909794 |
PublicationCentury | 2000 |
PublicationDate | 2021-Dec-04 |
PublicationDateYYYYMMDD | 2021-12-04 |
PublicationDate_xml | – month: 12 year: 2021 text: 2021-Dec-04 day: 04 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | medRxiv : the preprint server for health sciences |
PublicationTitleAlternate | medRxiv |
PublicationYear | 2021 |
References | 35298900 - Lancet Infect Dis. 2022 Jun;22(6):821-834. doi: 10.1016/S1473-3099(22)00069-X |
References_xml | |
Score | 1.8275532 |
Snippet | By August 2021, South Africa experienced three SARS-CoV-2 waves; the second and third associated with emergence of Beta and Delta variants respectively.
We... |
SourceID | pubmed |
SourceType | Index Database |
Title | SARS-CoV-2 incidence, transmission and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-2021 |
URI | https://www.ncbi.nlm.nih.gov/pubmed/34909794 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb5swFLbSTpr6MnXafd3kh70ROnAMhL1F0absQlUl6dS3yjZGjbRBREm17V_0f-xH7hwbE1Rl2uXFIthB4PNhHx8-f4eQVyqSY8VE6hcpvE1cy8CXidJ-iBHIQOOkinHI7CSenfEP59H5YPCzx1raNPJY_di5r-R_rArnwK64S_YfLNtdFE7AMdgXSrAwlH9l48VkvvCn1WefeRgyN-lBsc8anIDAgFeOa1xrR7oyxEbh1UZtwwq1eptaQnmlG7f7GZbgmy-W5IF-6ens_Xyx9KceZtOtGytJa8KmmH_Ps6mG8DfDVSIUYd_lhel2_m117TkGyRp1NFclXAbJlrXhOdrdmF47HXdufrd3ZArI-t5xQT7CQFZetisAFAlYdei8RpGQqmkca21SbmkDmcoqpziZYYpSDEF_6oc9WGgoJHz3oG-SDWAj1GFlwTFMxzHy7_qt4SHXXw0ORjwN0iTlf669pcTtqvbIXjLGNCEnp1krZAW38HrHDRyQu-5Pt5Ytxn1ZHpJ77bqDTiyI7pOBLh-Qmy2AaAegIe3DhwJGaA8-0I4KauBjqkRJDXxoC583tAUPrQoK5qYOPNSChxrwDKmBDrXQGdIOOA_J2bu3y-nMb3N0-IqB9-prEeYjyWSowyLUUmgY0LlIBBcj_IIsIq6VQAHMOEhFXvBYjVWhkyjM01zqImKPyH5ZlfoJoSoXI9Rr5IGKecgSGTCZoni8TqQokvQpeWx78GJthVguXN8--23Nc3KwBc8RuVPAm69fgBvZyJfGfr8AFr9xBg |
link.rule.ids | 780 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=SARS-CoV-2+incidence%2C+transmission+and+reinfection+in+a+rural+and+an+urban+setting%3A+results+of+the+PHIRST-C+cohort+study%2C+South+Africa%2C+2020-2021&rft.jtitle=medRxiv+%3A+the+preprint+server+for+health+sciences&rft.au=Cohen%2C+Cheryl&rft.au=Kleynhans%2C+Jackie&rft.au=von+Gottberg%2C+Anne&rft.au=McMorrow%2C+Meredith+L&rft.date=2021-12-04&rft_id=info:doi/10.1101%2F2021.07.20.21260855&rft_id=info%3Apmid%2F34909794&rft_id=info%3Apmid%2F34909794&rft.externalDocID=34909794 |